• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定新型拓扑异构酶 B 抑制剂作为潜在抗结核药物:同源建模、混合虚拟筛选和分子动力学模拟。

Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations.

机构信息

School of Health Sciences, University of KwaZulu-Natal, Durban, 4001, South Africa.

出版信息

Chem Biol Drug Des. 2013 Aug;82(2):205-15. doi: 10.1111/cbdd.12152.

DOI:10.1111/cbdd.12152
PMID:23614896
Abstract

Using an integrated computational approach involving homology modelling, pharmacophore/structure-based virtual screening, molecular dynamics simulations and per-residue energy contribution, 10 compounds were proposed as potential TB inhibitors. Via validated docking calculations, binding free energy calculations showed that the proposed compounds presented better binding affinity with DNA gyrase B when compared to novobiocin. The compiled in silico approach employed in this study may serve as a useful tool in the process of the design and development of drugs, not only against TB, but also for a wide range of biological systems.

摘要

采用同源建模、基于药效团/结构的虚拟筛选、分子动力学模拟和残基能量贡献分析等综合计算方法,提出了 10 种化合物作为潜在的结核分枝杆菌抑制剂。通过验证的对接计算,结合自由能计算表明,与新生霉素相比,所提出的化合物与 DNA 拓扑异构酶 B 具有更好的结合亲和力。本研究中使用的计算机模拟方法可以作为设计和开发药物的有用工具,不仅针对结核病,还针对广泛的生物系统。

相似文献

1
Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations.鉴定新型拓扑异构酶 B 抑制剂作为潜在抗结核药物:同源建模、混合虚拟筛选和分子动力学模拟。
Chem Biol Drug Des. 2013 Aug;82(2):205-15. doi: 10.1111/cbdd.12152.
2
In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.用于有效治疗耐药结核病的B结构域选择性回旋酶抑制剂的计算机辅助设计
Tuberculosis (Edinb). 2018 Sep;112:83-88. doi: 10.1016/j.tube.2018.08.005. Epub 2018 Aug 8.
3
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.结核分枝杆菌(MTB)gyrB 抑制剂:开发新型抗结核药物的一种有吸引力的方法。
Eur J Med Chem. 2016 Nov 29;124:160-185. doi: 10.1016/j.ejmech.2016.08.034. Epub 2016 Aug 20.
4
Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.取代苯并呋喃作为结核分枝杆菌DNA促旋酶B抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2014 Sep 1;22(17):4924-34. doi: 10.1016/j.bmc.2014.06.041. Epub 2014 Jun 27.
5
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.苯并噻嗪酮 - 哌嗪衍生物作为高效的结核分枝杆菌DNA回旋酶抑制剂
Int J Mycobacteriol. 2015 Jun;4(2):104-15. doi: 10.1016/j.ijmyco.2015.02.002. Epub 2015 Mar 26.
6
In silico study directed towards identification of the key structural features of GyrB inhibitors targeting MTB DNA gyrase: HQSAR, CoMSIA and molecular dynamics simulations.针对靶向 MTB DNA 回旋酶的 GyrB 抑制剂的关键结构特征的计算机研究:定量构效关系、比较分子相似性指数分析和分子动力学模拟。
SAR QSAR Environ Res. 2019 Nov;30(11):775-800. doi: 10.1080/1062936X.2019.1658218.
7
Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against and Hit Validation by Biological Assays.基于配体的虚拟筛选发现吲哚衍生物作为有效的 DNA 拓扑异构酶 ATP 酶抑制剂,针对 和通过生物测定进行命中验证。
J Chem Inf Model. 2024 Aug 12;64(15):5991-6002. doi: 10.1021/acs.jcim.4c00511. Epub 2024 Jul 12.
8
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.噻唑并嘧啶脲类作为新型抗结核药物,通过抑制 DNA 回旋酶 B 发挥作用。
J Med Chem. 2013 Nov 14;56(21):8834-48. doi: 10.1021/jm401268f. Epub 2013 Oct 18.
9
Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.噻唑-氨基哌啶杂合体类似物:新型结核分枝杆菌 GyrB 抑制剂的设计与合成。
Eur J Med Chem. 2013;70:143-53. doi: 10.1016/j.ejmech.2013.09.025. Epub 2013 Oct 3.
10
Enabling the (3 + 2) cycloaddition reaction in assembling newer anti-tubercular lead acting through the inhibition of the gyrase ATPase domain: lead optimization and structure activity profiling.通过抑制拓扑异构酶 ATP 酶结构域使(3+2)环加成反应在组装新型抗结核先导化合物中的应用:先导化合物优化和构效关系研究。
Org Biomol Chem. 2015 Feb 28;13(8):2423-31. doi: 10.1039/c4ob02049a.

引用本文的文献

1
Taxifolin as dual inhibitor of Mtb DNA gyrase and isoleucyl-tRNA synthetase: in silico molecular docking, dynamics simulation and in vitro assays.紫杉叶素作为结核分枝杆菌DNA回旋酶和异亮氨酰-tRNA合成酶的双重抑制剂:计算机模拟分子对接、动力学模拟及体外实验
In Silico Pharmacol. 2018 Apr 9;6(1):8. doi: 10.1007/s40203-018-0045-5. eCollection 2018.
2
Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.美国食品药品监督管理局(FDA)批准的抗HIV蛋白酶抑制剂会成为有前景的抗癌药物吗?基于增强对接方法和分子动力学分析的解答。
Drug Des Devel Ther. 2015 Nov 13;9:6055-65. doi: 10.2147/DDDT.S87653. eCollection 2015.